您现在位置：健康网-医药产业 >> 研究报告 >> English reports >> English reports >> 浏览医药行业研究报告

Lipid Regulating Drugs and Anti-artherosclerosis Drugs Report

健康网讯：

Market Research Report On Lipid Regulating Drugs and Anti-artherosclero
sis Drugs

Publisher: Orient Health Electronic Commercial(Beijing)co.,Ltd
Published:  July 2006 
Format:  Hardcopy and Adobe PDF 
Price:  US$3,500 
Contact: Mr. Bian chenghua   Ms. Wu huifang
Tel.: 86-10-68012929-2116/2101             Fax:  86-10-68012929-2008
E-mail: bianch@healthoo.com   wuhf@healthoo.com                      
http://www.healthoo.com

First part: Epidemiology of hyperlipemia
1 Conception of hyperlipemia
2 Types of hyperlipemia
3 Epidemiology of hyperlipemia in China
  3.1 Chinese blood-lipid level and distribution feature
  3.2 Morbidity rate
4 Catergories and product structure
5 Overview of Health food for lipids regulating
Second part: Market analysis
1 Market scale and growth trend of cardiovascular drugs
2 Overview about lipids regulating drugs marekt
  2.1 Academic market capacity
  2.2 Overview about hospital market and retail market
3 Analysis about hospital market
  3.1 Growth trend of lipids regulating drugs in the past few years
  3.2 Market shares of different categories
  3.3 Sales rank of breeds of lipids regulating drugs last year
  3.4 Sales analysis in key cities
  3.5 Sales analysis of Statin drugs
     3.5.1 Simvastatin(Zocor)
     3.5.2 Lovastatin(Mevacor)
     3.5.3 Pravastatin
     3.5.4 Fluvastatin(Lescol)
     3.5.5 Atorvastatin
     3.5.6 Rosuvastatin
     3.5.7 Compound preparation of Statins
       ezetimibe/Simvastatin （Vytorin）
       Torcetrapib/Atorvastatin
       MK-0524A/Zocor
       Statins+cholalic acid chelating agent
       Other compound preparation of Statins
  3.6 Fibrates
    3.6.1 Fenofibrate
    3.6.2 Gemfibrozil
  3.7 Nicotinic Acid class
    3.7.1 Tocopheryl Nicotinate
    3.7.2 Acipimox
  3.8 Prepared Chinese Medicine
    3.8.1 "ZhiBiTuo"
    3.8.2 "XueZhiKang"
    3.8.3 Gypenosides
  3.9 Heparins class
    3.9.1 Chondroitin A
    3.9.2 Alginic　Sodium　Diester
    3.9.3 Mannose　Ester
  3.10 Polyunsaturated fatty acid class
    3.10.1 Ethyl　Polyenoate
    3.10.2 Squalene
    3.10.3 Linoleic acid compound
    3.10.4 Evening primrose oil
    3.11 Analysis about manufacturing enterprises
    3.11.1 Market share of procucts made by domestic, foreign, joint
 venture enterprises
    3.11.2 Top 15 manufacturing enterprising last year
4 Analysis about retail market
  4.1 Market shares of different categories
  4.2 Sales rank of breeds of lipids regulating drugs
  4.3 Sales shares of different enterprises
    4.3.1 Statins
    4.3.2 Prepared Chinese Medicine
    4.3.3 Fibrates
    4.3.4 Polyunsaturated fatty acid class
    4.3.5  Nicotinic Acid class
  4.4 Enterprise list ranked by sales value
  4.5 Top 15 enterpsies ranked by sales value in different cities
     4.5.1 Beijing
     4.5.2 Shanghai
     4.5.3 Guangzhou
     4.5.4 Wuhan
     4.5.5 Shenyang
     4.5.6 chengdu
     4.5.7 hangzhou
     4.5.8 Shenzhen
     4.5.9 Shijiazhuang
     4.5.10 Zhengzhou